is mounjaro a glp-1 agonists Weight Loss Treatments: Ozempic, Mounjaro, and Other Options| PMN GLP-1 agonists approved for clinical
Description
PLoS One (2012) 7(6):e38744

Lacks transparency regarding the pricing
John Barlow has sat on advisory board panels and received honoraria from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Merck Sharp & Dohme, Mylan, Novartis and Sanofi/Aventis

And so these were originally type 2 diabetes treatments, and now they have since moved on to become weight-loss treatments
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
What we found: Currently the evidence does not show that GLP-1 medications increase the risk of depression or suicidality

Jenna Fink is senior director, research & advisory at Zero100.
